Homology Medicines Announces Preclinical Gene Therapy Candidate For Genetic Storage Disorder
Homology Medicines Inc (NASDAQ: FIXX) announced the details of HMI-204, its optimized, in vivo, one-time gene therapy candidate for metachromatic leukodystrophy (MLD).